cdk4

20
t
gbm
iv
60
50
shh
rb1
pnet
g1
ec
17q
n-myc
5-10
rcas-akt
tumor
rcas-pdgf
cns
17
non-cns
hg
mycn
rtks
on
23
1
smoa1
akt
ko
pdgf
mycc
gfap-cre
10-12
tg
ptk787
ras/mapk
xrcc4
am
preclinical
cd133
sh2
gfap
igf2
pi3k
rb
mouse
rcas-cre
gli
as
vegfr
gfapt121
models
gfap12
19q
c-myc
3
dna
pdgf-b
t121
ros
92
erbb
10
a
studies
cscs
12
sufu
100
30
3-5
remarks
c
nf1
brca2
gemm
to
300
smo
rtk
pdgfr
ink4a
ptch1
opg
tp53
lg
by
kras
dsbs
csc
in
rcas-shh
egfr
rcas-pdgf-b
rcas
glioma
196
of
mtor
ptc1
smom2
2-7
nd2
sv40
1-3
fig-ros
cdkn2a
s100ss
20x
15
2-4
1p
testing
li
momulv
~15
smoh
nfkb
40
mri
v12ras
egfrviii
arf
cdkn2/p16
b
147
ptch
nf1/p53
trp53
for
brain
ras
10-20
concluding
pten
an
s100-v-erbb
opgs
gemms
rcas-kras
using